Yossi Matias, Vice President & Head of Google Research, explores how AI is beginning to reshape biology, infrastructure, manufacturing, and science, and why its greatest impact may come when it intersects with other fields. Step inside the newsroom with our MIT Technology Review editors for sharp analysis and unpublished insights from the team that researches…
A stronger website experience does more than improve usability. It gives visitors the clarity, confidence and direction they need to take the next step.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Why “reprogramming” is the buzziest approach to reversing aging right now Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first…
The spy law known as Section 702, which authorizes the NSA and FBI’s warrantless surveillance, will all but certainly expire on Friday for the first time.
There we were, a regular murderers’ row of librarians. Little Jo. Eustace. And me. Turning around in the nave of our library to greet the sound of footsteps, pistols leveled in case whoever was coming in didn’t respect sanctuary. Little Jo had a stack of books under one arm. Eustace was holding the screwdriver she’d…
Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first volunteer. A person with glaucoma has had an experimental treatment injected straight into their eyeball. The idea is to try to treat the disease—which can cause vision loss—by regenerating healthy nerves in the eye. But…